Colon cancer eradication after chemoimmunotherapy is associated with intratumoral emergence of proinflammatory myeloid cells

OncoImmunology

Volumn 1, Issue 1, 2012, Pages 118-120

  Medina Echeverz, José ^a   Berraondo, Pedro ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Colorectal cancer; Cyclophosphamide; Inflammatory myeloid cells; Interleukin 12

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

BONE MARROW CELL; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; COLON CANCER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; INTERLEUKIN 12 GENE; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOLECULAR DYNAMICS; NONHUMAN; NOTE; ONCOGENE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT;

EID: 84877842088     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.1.1.18049     Document Type: Note

References (8)

1. Medina-Echeverz J, Fioravanti J, Zabala M, Ardaiz N, Prieto J, Berraondo P. Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells. J Immunol 2011; 807-15; DOI:10.4049/jimmunol.1001483.
2. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791-802.
3. Zabala M, Lasarte JJ, Perret C, Sola J, Berraondo P, Alfaro M, et al. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol 2007; 47:807-15; DOI:10.1016/j.jhep.2007.07.025.
4. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-86; DOI:10.1016/j.it.2004.09.015.
5. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; DOI:10.1016/S1471-4906(02)02302-5.
6. Berraondo P, Nouze C, Preville X, Ladant D, Leclerc C. Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive and regulatory components of the immune system. Cancer Res 2007; 67:8847-55; DOI:10.1158/0008-5472.CAN-07-0321.
7. Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, et al. mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res 2011; 71:4074-84; DOI:10.1158/0008-5472.CAN-10-3968.
8. Gonzalez-Aparicio M, Alzuguren P, Mauleon I, Medina-Echeverz J, Hervas-Stubbs S, Mancheno U, et al. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice. Gut 2011; 60:341-9; DOI:10.1136/gut.2010.211722.